Suivre
Leah V Sibener, PhD
Leah V Sibener, PhD
Adresse e-mail validée de stanford.edu
Titre
Citée par
Citée par
Année
Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes
JT Sockolosky, E Trotta, G Parisi, L Picton, LL Su, AC Le, A Chhabra, ...
Science 359 (6379), 1037-1042, 2018
3162018
Antigen identification for orphan T cell receptors expressed on tumor-infiltrating lymphocytes
MH Gee, A Han, SM Lofgren, JF Beausang, JL Mendoza, ME Birnbaum, ...
Cell 172 (3), 549-563. e16, 2018
2872018
Isolation of a structural mechanism for uncoupling T cell receptor signaling from peptide-MHC binding
LV Sibener, RA Fernandes, EM Kolawole, CB Carbone, F Liu, D McAffee, ...
Cell 174 (3), 672-687. e27, 2018
2752018
Crystal structure of Vδ1 T cell receptor in complex with CD1d-sulfatide shows MHC-like recognition of a self-lipid by human γδ T cells
AM Luoma, CD Castro, T Mayassi, LA Bembinster, L Bai, D Picard, ...
Immunity 39 (6), 1032-1042, 2013
2582013
Nanoscale artificial antigen presenting cells for T cell immunotherapy
K Perica, ADL Medero, M Durai, YL Chiu, JG Bieler, L Sibener, ...
Nanomedicine: Nanotechnology, Biology and Medicine 10 (1), 119-129, 2014
1622014
Genetic variation in MHC proteins is associated with T cell receptor expression biases
E Sharon, LV Sibener, A Battle, HB Fraser, KC Garcia, JK Pritchard
Nature genetics 48 (9), 995-1002, 2016
1592016
Structural interplay between germline interactions and adaptive recognition determines the bandwidth of TCR-peptide-MHC cross-reactivity
JJ Adams, S Narayanan, ME Birnbaum, SS Sidhu, SJ Blevins, MH Gee, ...
Nature immunology 17 (1), 87-94, 2016
1342016
Lysophospholipid presentation by CD1d and recognition by a human Natural Killer T‐cell receptor
J López‐Sagaseta, LV Sibener, JE Kung, J Gumperz, EJ Adams
The EMBO journal 31 (8), 2047-2059, 2012
752012
Tuning T cell receptor sensitivity through catch bond engineering
X Zhao, EM Kolawole, W Chan, Y Feng, X Yang, MH Gee, KM Jude, ...
Science 376 (6589), eabl5282, 2022
742022
Discovery of surrogate agonists for visceral fat Treg cells that modulate metabolic indices in vivo
RA Fernandes, C Li, G Wang, X Yang, CS Savvides, CR Glassman, ...
Elife 9, e58463, 2020
322020
Stress-testing the relationship between T cell receptor/peptide-MHC affinity and cross-reactivity using peptide velcro
MH Gee, LV Sibener, ME Birnbaum, KM Jude, X Yang, RA Fernandes, ...
Proceedings of the National Academy of Sciences 115 (31), E7369-E7378, 2018
272018
Identification of antigenic targets
HP Gerber, LV Sibener, LJ Lee, MH Gee
Trends in Cancer 6 (4), 299-318, 2020
102020
Intracellular targets as source for cleaner targets for the treatment of solid tumors
HP Gerber, LV Sibener, LJ Lee, M Gee
Biochemical Pharmacology 168, 275-284, 2019
102019
TCR ligand potency differentially impacts PD-1 inhibitory effects on diverse signaling pathways
W Chan, YM Cao, X Zhao, EC Schrom, D Jia, J Song, LV Sibener, S Dong, ...
Journal of Experimental Medicine 220 (12), e20231242, 2023
62023
Voices of biotech leaders
AE Abong, K Bosley, C Casebourn, P Chan, J Chen, M Chen, G Church, ...
Nature Biotechnology 39 (6), 654-660, 2021
52021
Isolation and visualization of a structural trigger that uncouples TCR signaling from pMHC binding
LV Sibener, RA Fernandes, EM Kolawole, CB Carbone, F Liu, D McAffee, ...
Cell 174 (3), 672, 2018
42018
Antigen-specificity of clonally-enriched CD8+ T cells in multiple sclerosis
K Mittl, F Hayashi, R Dandekar, RD Schubert, J Gerdts, L Oshiro, ...
bioRxiv, 2024.09. 07.611010, 2024
2024
T cell receptor (tcr) compositions and methods for optimizing antigen reactive t-cells
L Sibener, J Leonard, M Gee, J Byers
US Patent App. 18/157,605, 2023
2023
T cell receptor (tcr) compositions and methods for optimizing antigen reactive t-cells
L Sibener, J Leonard, A Ramirez, M Gee
US Patent App. 18/157,598, 2023
2023
T cell receptor (tcr) compositions and methods for optimizing antigen reactive t-cells
L Sibener, J Leonard, M Gee
US Patent App. 18/157,623, 2023
2023
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20